Synthesis of Credible Fluoro Nitro Containg Novel Benzopyrimidi

Authors(2) :-Dr. J. R. Shukla, Vikas Chauhan

Synthesis of a series of N-(substituted phenyl)-2-methyl-4-(4-(4-(trifluoro methyl)-2-nitrophenoxy) phenyl)-1,4-dihydropyrimido[1,2-a] benzimidazole-3-carboxamide products (4a-j) was completed from 4-(4-(trifluoromethyl)-2-nitrophenoxy)benzaldehyde, N-(substitutedphenyl)-3-oxobutanamides and using 2-amino benzimidazole in DMF reflux for 24 hrs, the product obtained was isolated. So to the outstanding yield. The structures of the products were supported by FTIR, 1H NMR and mass spectral data.

Authors and Affiliations

Dr. J. R. Shukla
Department of Chemistry, Shri C.N.P.F Arts & D. N.Science College, Dabhoi, Gujarat, India
Vikas Chauhan
Asstanr Manager, Apothecon Pharmaceutical, Dabhasa, Gujarat, India

N-(substitutedphenyl)-3-oxobutanamides, 4-(4-(trifluoromethyl)-2-nitrophenoxy)benzaldehyde, 2-amino benzimidazole and DMF only refluxed.

  1. Eussell, J. A. Annu. Rev. Biochem. 1945, 14, 309.
  2. Cox, R. A. Quart. Rev. 1968, 22, 934.
  3. Callery, P.; Gannett, P. Cancer and cancer chemotherapy. In Foye’s Principles of Medicinal Chemistry (eds Williams, D. A., Lemke, T. L.), Lippincott Williams and Wilkins, Philadelphia, 2002, 934.
  4. Al Safarjalani, O. N.; Zhou, X. J.; Ras, R. H.; Shi, J.; Schinazi, R. F.; Naguib, F. N.; El Kouni, M. H. Cancer Chemother. Pharmacol. 2005, 55, 541.
  5. Remers, W. A. Antineoplastic agents. In Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry (eds Delgado, J. N.; Remers, W. A.), Lippincott Williams and Wilkins, Philadelphia, 1998, 366.
  6. Elion, G. B. Fed. Proc. 1967, 26, 898.
  7. Burchenal, J. H. et al. Blood, 1953, 8, 965.
  8. Clarkson, B. D. Cancer 1970, 5, 227.
  9. Giller, S. A.; Zhuk, R. A.; Lidak, M. I. U. Dokl. Akad. Nauk. SSR 1967, 176, 332.
  10. Kompis I and Wick A; Helv. Chim. Acta, 1977; 60: 3025.
  11. Polak A. and Scholer HJ; Chemotherapy, 1975; 21: 113.
  12. Mishra A and Singh DV; Indian J. Hetero. Chem, 2004; 14: 43-46.
  13. Cheng CC and Roth B; In Progress in Medicinal Chem. (eds Ellis GP and West GB),Butterworths London; 1982; 19: 267.
  14. Aly A.A., Chinese Journal of Chem, 2005; 23: 211-217.
  15. Fahmy HTY, Rostom SAF, Saudi MN, Zjawiony JK, Robins DJ. Arch Pharm Pharm Med Chem, 2003; 3: 1-10.
  16. Jerzy Cleplik, Marcin Stolarczyk, Januzy Pluta, Olaf Gubrynowicz,Iwona Bryndal, Tadeusz Lis & Marcin Mikulewicz.,Acta Poloniae Pharmaceutica-Drug Research.,2011, 68(1), 57.
  17. The Merck Index, 14th edition (Whitehouse Station, USA, 2006).
  18. V.A. Anisimova, M.M. Osipova, A.A. Spasov, A.F. Turchaeva, G.P. Dudchenko, N.P. Larionov, S.G. Kovalcv, Pharm. Chem. J. 36, 468 (2002) .
  19. A. Settimo, G. Primofiore, F. Settimo, A.M. Marini, Il Farmaco 47, 1293 (1992)
  20. J.P. Powers, S. Li, J.C. Jaen, J. Liu, N.P.C. Walker, Z. Wang, H. Wesche, Bioorg. Med. Chem. Lett. 16, 2842 (2006)
  21. P.F. Asobo, H. Wahe, J.T.Mbafor, A.E. Nkengfack, Z.T. Fomum, E.F. Sophue, D. Döpp, J. Chem. Soc. Perkin Trans. 1, 457 (2001)
  22. J. Madden, J.R. Dod, R. Godemann, J. Kraemer, M. Smith, M. Biniszkiewicz, D.J. Hallett, J. Barker, J.D. Dyekjaer, T. Hesterkamp, Bioorg. Med. Chem. Lett. 20, 5329 (2010)
  23. P.P. Seth, E.A. Jefferson, L.M. Risen, S.A. Osgood, Bioorg.Med. Chem. 13, 1669 (2003)
  24. S.O. Podunavac-Kuzmanovi?, D.D. Cvetkovic, CI&CEQ 17, 9 (2011)
  25. T.A. Farghaly, N.A.A. Hafez, E.A. Ragab, H.M. Awad, M.M. Abdalla, Eur. J. Med. Chem. 45, 492 (2010)
  26. (a) W.P. Nawrocka, Boll. Chim. Farm. 135, 18 (1996); (b) W.P. Nawrocka, A. Nowicka, H. Liszkiewicz, Wiad. Chem. 66, 811 (2012) (in Polish)
  27. W.P. Nawrocka, A. Nowicka, H. Liszkiewicz, Wiad. Chem. 66, 839 (2012) (in Polish)
  28. W.P. Nawrocka, A. Nowicka, Wiad. Chem. 67, 715 (2013) (in Polish)
  29. A. Nowicka, W.P. Nawrocka, Wiad. Chem. 67, 695 (2013) (in Polish)
  30. A. Nowicka, W.P. Nawrocka, Wiad. Chem. 67, 203 (2013) (in Polish)
  31. National Committee for Clinical and Laboratory Standards, Method forDilution Antimicrobial Susceptibility Tests for Bacteria that GrowAerobically Approved Standard, fourth ed. NCCLS, Villanova, Italy, 1997,Document M 100-S7. S100-S157.
  32. Isenberg, D. H. Essential Procedure for Clinical Microbiology, American Society for Microbiology, Washington, 1998.
  33. Zgoda, J. R.; Porter, J. R. Pharm. Biol. 2001, 39, 221.

Publication Details

Published in : Volume 2 | Issue 6 | November-December 2016
Date of Publication : 2016-12-31
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 747-753
Manuscript Number : IJSRSET11529
Publisher : Technoscience Academy

Print ISSN : 2395-1990, Online ISSN : 2394-4099

Cite This Article :

Dr. J. R. Shukla, Vikas Chauhan, " Synthesis of Credible Fluoro Nitro Containg Novel Benzopyrimidi, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 2, Issue 6, pp.747-753, November-December-2016.
Journal URL : http://ijsrset.com/IJSRSET11529

Follow Us

Contact Us